3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
2
von Hippel-Lindau Disease
1
Triple Negative Breast Neoplasms
1
Sarcoma, Kaposi
1
Sarcoma
1
Neoplasm Metastasis
1
Metastatic Digestive System Neuroendocrine Tumor G1
1
Meningioma
1
Liposarcoma
1
Leiomyosarcoma
1
Hamartoma Syndrome, Multiple
1
Glioma
1
Glioblastoma
1
Endometrial Neoplasms
1
Diffuse Intrinsic Pontine Glioma
1
Carcinoma, Renal Cell
1
Brain Neoplasms
1
Bone Neoplasms
1
Autistic Disorder
1
Astrocytoma
1
Interventions
Oxaliplatin
3
Leucovorin
3
Fluorouracil
3
Capecitabine
3
zolbetuximab
2
trastuzumab deruxtecan
2
pembrolizumab
2
Ramucirumab
2
Paclitaxel
2
repotrectinib
1
lenvatinib
1
fludarabine
1
enzalutamide
1
durvalumab
1
darolutamide
1
aldesleukin
1
Vinorelbine
1
Radiosurgery
1
Radiation
1
Prednisone
1
Prednisolone
1
Positron-Emission Tomography
1
Pemetrexed
1
PF06821497
1
Nivolumab
1
Negative-Pressure Wound Therapy
1
Microscopy, Confocal
1
MORAb-202
1
Irinotecan
1
Immunotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma
×
Everolimus
×
30 days
×
Clear all
No trials found.